n-methylaspartate has been researched along with Diabetes Mellitus, Type 2 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Van Hove, L | 1 |
Azmoon, P; Das, L; Gonias, SL; Gunner, CB; Mantuano, E; Pizzo, SV; Zampieri, C | 1 |
Chen, C; Cheng, QM; Feng, DD; Hao, CX; Huang, XT; Huang, YH; Ji, M; Li, C; Li, XH; Luo, ZQ; Wang, LZ; Xu, JP; Yue, SJ | 1 |
Das, UN | 1 |
1 review(s) available for n-methylaspartate and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period?
Topics: Animals; Appetite Regulation; Arachidonic Acid; Brain; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Dopamine; Eicosapentaenoic Acid; Fatty Acids, Essential; Fatty Acids, Unsaturated; gamma-Aminobutyric Acid; Humans; Hypothalamus, Middle; Infant, Newborn; Inflammation; Insulin; Leptin; Metabolic Syndrome; N-Methylaspartate; Neurons; Qa-SNARE Proteins; Receptor, Insulin; Receptors, Retinoic Acid; Serotonin; Synapses | 2007 |
3 other study(ies) available for n-methylaspartate and Diabetes Mellitus, Type 2
Article | Year |
---|---|
A Cannabinoid Type 2 (CB2) Receptor Agonist Augments NOS-Dependent Responses of Cerebral Arterioles During Type 1 Diabetes.
Topics: Adenosine Diphosphate; Animals; Arterioles; Cannabinoid Receptor Agonists; Cannabinoids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ethanol; N-Methylaspartate; Nitric Oxide Synthase; Nitroglycerin; Rats; Rats, Sprague-Dawley; Vasodilation | 2022 |
An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages.
Topics: Antibodies; Cytokines; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Chaperone BiP; Humans; Low Density Lipoprotein Receptor-Related Protein-1; Macrophages; Membrane Proteins; N-Methylaspartate; Plasminogen Inactivators | 2023 |
A Sustained Activation of Pancreatic NMDARs Is a Novel Factor of β-Cell Apoptosis and Dysfunction.
Topics: Animals; Apoptosis; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Insulin-Secreting Cells; Male; Mice; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2017 |